Omeros (OMER)
(Real Time Quote from BATS)
$3.82 USD
-0.08 (-2.05%)
Updated Sep 25, 2024 03:04 PM ET
4-Sell of 5 4
F Value F Growth D Momentum F VGM
Income Statements
Fiscal Year end for Omeros Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 74 | 112 |
Cost Of Goods | 0 | 0 | 0 | 1 | 1 |
Gross Profit | 0 | 0 | 0 | 73 | 111 |
Selling & Adminstrative & Depr. & Amort Expenses | 165 | 163 | 174 | 184 | 174 |
Income After Depreciation & Amortization | -165 | -163 | -174 | -111 | -63 |
Non-Operating Income | 20 | 4 | 2 | -13 | 2 |
Interest Expense | 31 | 23 | 20 | 27 | 23 |
Pretax Income | -175 | -182 | -192 | -150 | -84 |
Income Taxes | 0 | 0 | 0 | -12 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -175 | -182 | -192 | -138 | -84 |
Extras & Discontinued Operations | 57 | 229 | 386 | 0 | 0 |
Net Income (GAAP) | -118 | 47 | 194 | -138 | -84 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -164 | -162 | -172 | -109 | -62 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 2 | 2 |
Income After Depreciation & Amortization | -165 | -163 | -174 | -111 | -63 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 62.74 | 62.74 | 62.34 | 57.18 | 49.52 |
Diluted EPS Before Non-Recurring Items | -2.79 | -2.77 | -2.45 | -1.84 | -0.96 |
Diluted Net EPS (GAAP) | -1.88 | 0.76 | 3.12 | -2.41 | -1.71 |
Fiscal Year end for Omeros Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 59.16 | 39.03 | 39.77 | 48.15 | 40.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | -59.16 | -39.03 | -39.77 | -48.15 | -40.90 |
Non-Operating Income | 3.25 | 3.42 | 7.54 | 4.41 | 4.54 |
Interest Expense | 9.22 | 8.23 | 7.06 | 7.92 | 7.93 |
Pretax Income | -65.13 | -43.85 | -39.29 | -51.66 | -44.29 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -65.13 | -43.85 | -39.29 | -51.66 | -44.29 |
Extras & Discontinued Operations | 9.08 | 6.67 | 30.22 | 13.91 | 7.00 |
Net Income (GAAP) | -56.04 | -37.18 | -9.07 | -37.75 | -37.29 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 57.94 | 58.80 | 62.44 | 62.86 | 62.84 |
Diluted EPS Before Non-Recurring Items | -1.12 | -0.74 | -0.63 | -0.82 | -0.70 |
Diluted Net EPS (GAAP) | -0.97 | -0.63 | -0.15 | -0.60 | -0.59 |